Inhibition of camitine-acyl transferase I by oxfenicine studied in vivo with [11C]-labeled fatty acids

被引:9
|
作者
Angsten, G [1 ]
Valind, S
Takalo, R
Neu, H
Meurling, S
Långström, B
机构
[1] Univ Uppsala, Childrens Hosp, Dept Pediat, S-75185 Uppsala, Sweden
[2] Univ Uppsala, PET Ctr, S-75105 Uppsala, Sweden
[3] Univ Uppsala Hosp, Dept Clin Physiol, S-75185 Uppsala, Sweden
[4] Univ Uppsala, Dept Organ Chem, S-75124 Uppsala, Sweden
基金
日本科学技术振兴机构;
关键词
carnitine; myocardial metabolism; fatty acid oxidation; PET; oxfenicine;
D O I
10.1016/j.nucmedbio.2005.03.003
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Methods: Anesthetized pigs were studied with [C-11]-labeled fatty acids (FAs) with carbon chain length ranging from 8 to 16 carbon atoms, during control conditions and during inhibition of carnitine-palmitoyl transferase I (CPT I) with oxfenicine. The myocardial uptake of [C-11]FAs from blood was measured together with the relative distribution of [C-11]-acyl-CoA between rapid mitochondrial oxidation and incorporation into slow turnover lipid pools in the heart. Results: During baseline conditions, the fractional oxidative utilization of palmitate was almost as high as that of carnitine-independent short-chain FAs, unless the carnitine shuttle was inhibited by high levels of lactate. Inhibition of CPT I almost completely blocked the oxidative pathway for palmitic acid and reduced the fractional oxidative utilization, while the rate of oxidative metabolism of acyl-CoA was unaffected. Conclusions: [C-11]-Labeled FAs allow rapid oxidation to be well separated from esterification into slow turnover lipid pools in the heart of anaesthetized pigs. The fractional oxidative utilization of [C-11]-palmitate serves well to characterize, in vivo, the carnitine-dependent transfer of long-chain FAs. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:495 / 503
页数:9
相关论文
共 7 条
  • [1] A new approach for the synthesis of [11C]-labeled fatty acids
    Wüst, F
    Dence, CS
    McCarthy, TJ
    Welch, MJ
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2000, 43 (13): : 1289 - 1300
  • [2] A new approach for the synthesis of [11C]-labeled fatty acids
    Wüst, F.
    Dence, C.S.
    McCarthy, T.J.
    Welch, M.J.
    Journal of Labelled Compounds and Radiopharmaceuticals, 2000, 43 (13) : 1289 - 1300
  • [3] EFFECT OF IMPAIRED FATTY-ACID OXIDATION ON MYOCARDIAL KINETICS OF C-11 LABELED AND I-123 LABELED FATTY-ACIDS
    LERCH, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1986, 12 : S36 - S38
  • [4] STUDIES OF CARDIAC METABOLISM WITH I-123-LABELED FATTY-ACIDS AND METHYLGLUCOSE-C-11
    VYSKA, K
    HOCK, A
    FREUNDLIEB, C
    BECKER, V
    SCHMID, A
    FEINENDEGEN, LE
    KLOSTER, G
    STOCKLIN, G
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 1981, 20 (03): : 148 - 155
  • [5] PREPARATION AND QUALITY-CONTROL OF C-11-LABELED, CL-34M-LABELED, BR-77-LABELED AND I-23-LABELED FATTY-ACIDS FOR KINETIC STUDIES OF HEART-MUSCLE METABOLISM
    MACHULLA, HJ
    STOCKLIN, G
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1977, 13 (02): : 221 - 221
  • [6] SYNTHESIS OF FATTY-ACIDS SPECIFICALLY LABELED WITH C-11 IN VARIOUS POSITIONS, INCLUDING H-2 SUBSTITUTION, FOR IN-VIVO STUDIES OF MYOCARDIUM USING PET
    KIHLBERG, T
    VALIND, S
    LANGSTROM, B
    NUCLEAR MEDICINE AND BIOLOGY, 1994, 21 (08): : 1053 - 1065
  • [7] COMPARATIVE EVALUATION OF FATTY-ACIDS LABELED WITH C-11, CL-34M, BR-77, AND I-123 FOR METABOLIC STUDIES OF MYOCARDIUM
    MACHULLA, HJ
    STOCKLIN, G
    KUPFERNAGEL, C
    FREUNDLIEB, C
    HOCK, A
    VYSKA, K
    FEINENDEGEN, LE
    JOURNAL OF NUCLEAR MEDICINE, 1978, 19 (03) : 298 - 302